Background Evidence increasingly suggested that impaired respiratory function remained in
about 40% of patients with coronavirus disease 2019 (COVID-19) after discharge …

This expert group consensus statement emphasises the need for standardising the definition
of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis …

Background: Despite the known benefits of pulmonary rehabilitation (PR) for patients with
chronic respiratory disease, this treatment is underused. Evidence-based guidelines should …

Rationale: Pulmonary rehabilitation (PR) has demonstrated physiological, symptom-
reducing, psychosocial, and health economic benefits for patients with chronic respiratory …

Background: Pulmonary rehabilitation is recognized as a core component of the
management of individuals with chronic respiratory disease. Since the 2006 American …

Background Interstitial lung disease (ILD) is characterised by reduced functional capacity,
dyspnoea and exercise‐induced hypoxia. Pulmonary rehabilitation is often used to improve …

Background: Dyspnea is a common, distressing symptom of cardiopulmonary and
neuromuscular diseases. Since the ATS published a consensus statement on dyspnea in …

Aim Pulmonary rehabilitation has established itself as a key management strategy in people
with chronic respiratory disease. The role of pulmonary rehabilitation has recently been …

Objective: Survivors of severe critical illness frequently develop substantial and persistent
physical complications, including muscle weakness, impaired physical function, and …

The literature of acute exacerbation of chronic obstructive pulmonary disease (COPD) is fast
expanding. This review focuses on several aspects of acute exacerbation of COPD …